Wolverine Trading, LLC Catalent, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $1.21 Million - $1.7 Million	-28,500 Reduced 88.24%	3,800 $214,000
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $1.73 Million - $2.51 Million	-53,800 Reduced 62.49%	32,300 $1.45 Million
Q3 2023 Nov 15, 2023	SELL	$44.2 - $50.2 $1.25 Million - $1.42 Million	-28,300 Reduced 24.74%	86,100 $3.92 Million
Q2 2023 Aug 23, 2023	BUY	$31.86 - $67.26 $1.45 Million - $3.06 Million	45,500 Added 66.04%	114,400 $4.96 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $3.13 Million - $5.12 Million	68,900 New	68,900 $4.46 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $180,900 - $282,750	2,500 Added 59.52%	6,700 $498,000
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $488,320 - $638,680	-5,600 Reduced 57.14%	4,200 $446,000
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $18,838 - $24,898	200 Added 2.08%	9,800 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $11,957 - $13,907	-100 Reduced 1.03%	9,600 $1.23 Million
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $393,012 - $512,460	-3,600 Reduced 27.07%	9,700 $1.3 Million
Q2 2021 Aug 06, 2021	BUY	$100.34 - $115.69 $20,068 - $23,138	200 Added 1.53%	13,300 $1.45 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $872,986 - $1.08 Million	8,600 Added 191.11%	13,100 $1.36 Million
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $463,752 - $568,944	-5,400 Reduced 54.55%	4,500 $464,000
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $407,344 - $518,000	-5,600 Reduced 36.13%	9,900 $843,000
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $744,310 - $1.23 Million	15,500 New	15,500 $1.12 Million
Q3 2019 Nov 14, 2019	SELL	$47.45 - $58.05 $403,325 - $493,425	-8,500 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$39.26 - $54.21 $447,564 - $617,994	-11,400 Reduced 57.29%	8,500 $461,000
Q1 2019 May 15, 2019	BUY	$29.84 - $43.92 $593,816 - $874,008	19,900 New	19,900 $808,000
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $176,705 - $273,406	-5,900 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$40.12 - $45.55 $152,456 - $173,090	-3,800 Reduced 39.18%	5,900 $269,000
Q1 2018 May 15, 2018	BUY	$39.4 - $47.39 $181,240 - $217,994	4,600 Added 90.2%	9,700 $398,000
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $14,908 - $17,208	-400 Reduced 7.27%	5,100 $210,000
Q3 2017 Nov 15, 2017	BUY	$33.75 - $41.67 $185,625 - $229,185	5,500	5,500 $220,000

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

Vanguard Group Inc Valley Forge, PA

20.2M
Shares

$1.28 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

15.4M
Shares

$975 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$473 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$406 Million
0.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$287 Million
0.14% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account